930 related articles for article (PubMed ID: 22138844)
21. The measurement of IgA and IgG transglutaminase antibodies in celiac disease: a comparison with current diagnostic methods.
Reeves GE; Burns C; Hall ST; Gleeson M; Lemmert K; Clancy RL
Pathology; 2000 Aug; 32(3):181-5. PubMed ID: 10968391
[TBL] [Abstract][Full Text] [Related]
22. The natural history of gluten sensitivity: report of two new celiac disease patients resulting from a long-term follow-up of nonatrophic, first-degree relatives.
Niveloni S; Pedreira S; Sugai E; Vazquez H; Smecuol E; Fiorini A; Cabanne A; Dezi R; Valero J; Kogan Z; Maurino E; Bai JC
Am J Gastroenterol; 2000 Feb; 95(2):463-8. PubMed ID: 10685751
[TBL] [Abstract][Full Text] [Related]
23. [Significance of a method for determination of deamidated gliadin peptide in the diagnosis of celiac disease].
Sabelnikova EA; Parfenov AI; Krums LM; Gudkova RB; Sagynbaeva VE; Bykova SV
Ter Arkh; 2014; 86(2):39-43. PubMed ID: 24772506
[TBL] [Abstract][Full Text] [Related]
24. Serologic screening for celiac disease in children: a comparison between established assays and tests with deamidated gliadin-derived peptides plus conjugates for both IgA and IgG antibodies.
Aberg AK; Olcén P
APMIS; 2009 Nov; 117(11):808-13. PubMed ID: 19845531
[TBL] [Abstract][Full Text] [Related]
25. Production of antibodies to gliadin by peripheral blood lymphocytes in children with celiac disease: the use of an enzyme-linked immunospot technique for screening and follow-up.
Hansson T; Dannaeus A; Kraaz W; Sjöberg O; Klareskog L
Pediatr Res; 1997 Apr; 41(4 Pt 1):554-9. PubMed ID: 9098859
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of antigliadin antibodies as a screening test for celiac disease in children.
Chartrand LJ; Agulnik J; Vanounou T; Russo PA; Baehler P; Seidman EG
CMAJ; 1997 Sep; 157(5):527-33. PubMed ID: 9294391
[TBL] [Abstract][Full Text] [Related]
27. Clinical evaluation of the BioPlex 2200 Celiac IgA and IgG Kits - a novel multiplex screen incorporating an integral check for IgA deficiency.
Holding S; Wilson F; Spradbery D
J Immunol Methods; 2014 Mar; 405():29-34. PubMed ID: 24424297
[TBL] [Abstract][Full Text] [Related]
28. Persistently positive gliadin antibodies without transglutaminase antibodies in the elderly: gluten intolerance beyond coeliac disease.
Ruuskanen A; Luostarinen L; Collin P; Krekelä I; Patrikainen H; Tillonen J; Laurila K; Haimila K; Partanen J; Mäki M; Valve R; Kaukinen K
Dig Liver Dis; 2011 Oct; 43(10):772-8. PubMed ID: 21641886
[TBL] [Abstract][Full Text] [Related]
29. Screening for coeliac disease in families of adults with Type 1 diabetes based on serological markers.
Matteucci E; Cinapri V; Quilici S; Lucchetti A; Mugnaini P; Giampietro O
Diabetes Nutr Metab; 2001 Feb; 14(1):37-42. PubMed ID: 11345164
[TBL] [Abstract][Full Text] [Related]
30. Antigliadin immunoglobulin A best in finding celiac disease in children younger than 18 months of age.
Lagerqvist C; Dahlbom I; Hansson T; Jidell E; Juto P; Olcén P; Stenlund H; Hernell O; Ivarsson A
J Pediatr Gastroenterol Nutr; 2008 Oct; 47(4):428-35. PubMed ID: 18852634
[TBL] [Abstract][Full Text] [Related]
31. Antiendomysial antibody detection in fecal supernatants: in vivo proof that small bowel mucosa is the site of antiendomysial antibody production.
Picarelli A; Sabbatella L; Di TM; Di CT; Vetrano S; Anania MC
Am J Gastroenterol; 2002 Jan; 97(1):95-8. PubMed ID: 11808976
[TBL] [Abstract][Full Text] [Related]
32. Serologic assay for diagnosis of celiac disease based on a patient-derived monoclonal antigliadin antibody.
Steinsbø Ø; Dørum S; Lundin KE; Sollid LM
Gastroenterology; 2015 Nov; 149(6):1530-1540.e3. PubMed ID: 26208894
[TBL] [Abstract][Full Text] [Related]
33. IgA antibodies against deamidated gliadin peptides in patients with chronic liver diseases.
Gatselis NK; Zachou K; Norman GL; Tzellas G; Speletas M; Gabeta S; Germenis A; Koukoulis GK; Dalekos GN
Clin Chim Acta; 2012 Oct; 413(19-20):1683-8. PubMed ID: 22643316
[TBL] [Abstract][Full Text] [Related]
34. [A comparison between antigliadin antibodies and blood xylose in celiac disease].
Barbato M; Frediani T; Lucarelli S; Viola F; Iulinella VR; Cao M; Contestabile G; Farinelli C; Principessa L; Nobili V
Minerva Pediatr; 1991 Sep; 43(9):563-6. PubMed ID: 1758392
[TBL] [Abstract][Full Text] [Related]
35. Antibodies to gliadin, endomysium, and tissue transglutaminase for the diagnosis of celiac disease.
Vitoria JC; Arrieta A; Arranz C; Ayesta A; Sojo A; Maruri N; García-Masdevall MD
J Pediatr Gastroenterol Nutr; 1999 Nov; 29(5):571-4. PubMed ID: 10554125
[TBL] [Abstract][Full Text] [Related]
36. [Relevance of anti-tissue transglutaminase antibodies in coeliac disease diagnosis].
Lepers S; Soula F; Fily S; Fontaine E; Vuye S; Colombel JF; Guimber D; Prin L; Dubucquoi S
Ann Biol Clin (Paris); 2003; 61(3):337-43. PubMed ID: 12805013
[TBL] [Abstract][Full Text] [Related]
37. Serum and intestinal celiac disease-associated antibodies in children with celiac disease younger than 2 years of age.
Maglio M; Tosco A; Paparo F; Auricchio R; Granata V; Colicchio B; Indolfi V; Miele E; Troncone R
J Pediatr Gastroenterol Nutr; 2010 Jan; 50(1):43-8. PubMed ID: 19934769
[TBL] [Abstract][Full Text] [Related]
38. Coeliac disease in Iraqi type 1 diabetic patients.
Mansour AA; Najeeb AA
Arab J Gastroenterol; 2011 Jun; 12(2):103-5. PubMed ID: 21684484
[TBL] [Abstract][Full Text] [Related]
39. Accuracy of testing for antibodies to synthetic gliadin-related peptides in celiac disease.
Sugai E; Vázquez H; Nachman F; Moreno ML; Mazure R; Smecuol E; Niveloni S; Cabanne A; Kogan Z; Gómez JC; Mauriño E; Bai JC
Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1112-7. PubMed ID: 16860613
[TBL] [Abstract][Full Text] [Related]
40. Gliadin does not induce mucosal inflammation or basophil activation in patients with nonceliac gluten sensitivity.
Bucci C; Zingone F; Russo I; Morra I; Tortora R; Pogna N; Scalia G; Iovino P; Ciacci C
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1294-1299.e1. PubMed ID: 23639603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
